Dear colleagues!
I welcome you on behalf of the Organizing Committee of the XI International Forum for Cardiology and Internal Medicine, which will be held from March 22 to 24, 2022 in Moscow.
Polypill Shows LDL-Lowering Advantage in High-risk Primary Prevention Patients: VULCANO
Key Takeaways
The CNIC (Centro Nacional de Investigaciones Cardiovasculares) polypill contains acetylsalicylic acid (100 mg), atorvastatin (30 mg or 40 mg), and ramipril (2.5 mg, 5 mg, or 10 mg), and is the only polypill for cardiovascular disease (CVD) currently marketed in European countries.
Current Overview on Hypercoagulability in COVID-19
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies, such as coagulopathy, prompting a desperate need for effective management. COVID-19-associated coagulopathy (CAC) can cause various thromboembolic complications, especially in critically ill patients.
ESC/EACTS to Review Left Main Revascularization Guidance Patrice Wendling
The European Society of Cardiology and European Association for Cardiothoracic Surgery (ESC/EACTS) have announced they will review their joint recommendations for left main coronary artery disease in light of emerging data.
Russian National Congress of Cardiology 2020
CONFERENCE NEWS
World Heart Day
On World Heart Day, 29 September 2020, we’re asking the world to Use Heart to beat CVD ... for your loved ones, society and you.
European Society of Cardiology (ESC) Congress 2020.
CONFERENCE NEWS
Major Indexing Service Calls Out Cardiology Journals for Self-Citation
More than 70% of the citations in one journal were to other papers in that journal. Another published a single paper that cited nearly 200 other articles in the journal.
Novel Lipid Therapies: 5 Things to Know
The development of novel pharmacotherapies targeting low-density lipoprotein (LDL), lipoprotein a, and triglycerides (TG) to help prevent patients' risk of atherosclerotic cardiovascular disease (ASCVD) has accelerated during the past decade.
COVID-19 and cardiovascular diseases: main aspects
Igor S. Yavelov MD, PhD, Professor of cardiology
RU
EN